April 21st, 2010 by Edwin Leap, M.D. in Better Health Network, Health Policy, Opinion
No Comments »
I’m always fascinated by the complaints that the emergency department is so overused and expensive. I admit that it is used a lot, and that care can seem expensive. But I want to make it clear that the reasons are myriad.
Whenever we in the specialty say that we feel that patients abuse our services, someone in academia reminds us that only a small number of those patients do not actually have serious illnesses. Whether or not that’s true, one of the reasons we are overused is due to none other than other physicians.
I’ve been paying attention lately to the way physician referral patterns happen. I suspect it’s the same in other facilities. Read more »
*This blog post was originally published at edwinleap.com*
April 10th, 2010 by Toni Brayer, M.D. in Better Health Network, Opinion, True Stories
No Comments »
The cost of medical care is high because the human body is complicated and doctors and patients hate ambiguity. The cost is high because a missed diagnosis can lead to death and a large lawsuit. The cost is high because we have many specialists who view the human body in their own tiny pieces and they want to feel 100 percent correct about their piece. Let me give you a real-life example. Read more »
*This blog post was originally published at EverythingHealth*
October 6th, 2009 by DrWes in Better Health Network, Health Policy, News
No Comments »
I just finished our first day at the Principle Investigator Meeting for the launch of the Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial in Philadelphia today. The trial is a 3000-patient patient trial performed at 140 centers around the world and jointly sponsored by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), and industry (St. Jude Medical and Biosense Webster).
The trial will randomize 3000 previously untreated or incompletely treated patients at high risk of cardiovascular complications in the trial to two arms: 1500 patients to catheter ablation as primary therapy of atrial fibrillation and the other 1500 patients to conventional medical therapy with rate control or rhythm control strategies to determine if catheter ablation is superior to medical therapy at reducing total mortality (the primary endpoint). Secondary endpoints of a composite endpoint of mortality, disabling stroke, serious bleeding, or cardiac arrest will also be studied.
If done properly, this study stands to be a landmark trial for the field of cardiac electrophysiology and has huge ramifications for the treatment of patients with atrial fibrillation. Also, it doesn’t take a lot of rocket science to know that the government will be looking closely at the results of this trial to determine which treatment strategy will receive government funding. Read more »
*This blog post was originally published at Dr. Wes*
